Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
Appointed director

PhaseBio Pharmaceuticals Inc (PHAS) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/19/2023 4 van den Broek Richard (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 3,750 shares @ $0
Exercised 3,750 restricted stock units @ $0
05/19/2023 4 Thorp Clay (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Exercised 3,750 restricted stock units @ $0
05/19/2023 4 Humphries William D. (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Exercised 2,538 restricted stock units @ $0
05/19/2023 4 HARRIGAN EDMUND (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Exercised 3,750 restricted stock units @ $0
05/19/2023 4 Sapir Alex (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Exercised 3,750 restricted stock units @ $0
05/19/2023 4 Loewy Caroline M (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Exercised 3,750 restricted stock units @ $0
05/19/2023 4 Hutson Nancy J (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Exercised 3,750 restricted stock units @ $0
10/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2022 4 Hanson Kristopher (SVP and General Counsel) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 4,831 shares @ $0.6813, valued at $3.3k
05/24/2022 4 Birchall Jonathan (Chief Commercial Officer) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 20,000 shares @ $0.6813, valued at $13.6k
05/24/2022 4 Sharp John P (CFO) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 6,026 shares @ $0.6813, valued at $4.1k
05/20/2022 4 Humphries William D. (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 17,500 options to buy @ $0.8419, valued at $14.7k
Granted 3,750 restricted stock units @ $0
05/20/2022 4 Thorp Clay (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 17,500 options to buy @ $0.8419, valued at $14.7k
Granted 3,750 restricted stock units @ $0
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Sapir Alex (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 17,500 options to buy @ $0.8419, valued at $14.7k
Granted 3,750 restricted stock units @ $0
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/28/2022 4 Sharp John P (CFO) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 24,750 restricted stock units @ $0
Granted 115,500 options to buy @ $1.13, valued at $130.5k
02/28/2022 4 Burkhardt Glen (VP, Human Resources) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 18,750 restricted stock units @ $0
Granted 87,500 options to buy @ $1.13, valued at $98.9k
02/28/2022 4 Birchall Jonathan (Chief Commercial Officer) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 11,250 restricted stock units @ $0
Granted 52,500 options to buy @ $1.13, valued at $59.3k
02/28/2022 4 Lee John Sang (Chief Medical Officer) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 24,750 restricted stock units @ $0
Granted 115,500 options to buy @ $1.13, valued at $130.5k
02/28/2022 4 Arnold Susan Elizabeth (SVP, Technical Operations) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 18,750 restricted stock units @ $0
Granted 87,500 options to buy @ $1.13, valued at $98.9k
02/28/2022 4 Hanson Kristopher (VP, Head of Legal) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 18,750 restricted stock units @ $0
Granted 87,500 options to buy @ $1.13, valued at $98.9k
02/28/2022 4 Mow Jonathan P (CEO) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 82,500 restricted stock units @ $0
Granted 385,000 options to buy @ $1.13, valued at $435.1k
11/23/2021 4 Mow Jonathan P (CEO) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 5,623 shares @ $2.01, valued at $11.3k
11/23/2021 4 Arnold Susan Elizabeth (SVP, Technical Operations) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 2,559 shares @ $2.01, valued at $5.1k
11/23/2021 4 Sharp John P (CFO) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 2,017 shares @ $2.01, valued at $4.1k
11/23/2021 4 Hanson Kristopher (VP, Head of Legal) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 1,545 shares @ $2.01, valued at $3.1k
11/23/2021 4 Burkhardt Glen (VP, Human Resources) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 5,766 shares @ $2.01, valued at $11.6k
Sold 5,766 shares @ $2.37, valued at $13.7k
11/09/2021 4 Birchall Jonathan (Chief Commercial Officer) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 250,000 options to buy @ $3.37, valued at $842.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy